Clinical Trial Update: Quality of Life and Changes in Metabolism of Lipids and Glucose After Switching to a Nevirapine-based Regimen in HIV+ Patients [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated quality of life and metabolic changes in HIV-infected patients after switching to a nevirapine-based antiretroviral regimen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• NEVIRAPINE (nevirapine)
• Viramune (Nevirapine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections, Quality of Life | Phase 4 | Status: COMPLETED